Back to Authors

Hainy, Caitlin M

Mayo Clinic

Division of Preventive, Occupational, and Aerospace Medicine, Mayo Clinic, Rochester, Minnesota, USA.

Citations 1

Effectiveness of Messenger RNA Coronavirus Disease 2019 (COVID-19) Vaccines Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in a Cohort of Healthcare Personnel
Swift, Melanie D. , Breeher, Laura E. , Tande, Aaron J. , Tommaso, Christopher P., Hainy, Caitlin , Chu, Haitao , Berbari, Elie F. , Virk, Abinash , Hainy, Caitlin M, Tande, Aaron , Swift, Melanie D , Chu, Haitao , Breeher, Laura , Hainy, Caitlin M. , Murad, M. Hassan

Clinical Infectious Diseases | April 23, 2021 | Volume: 73 | Issue: 6 | Pages: e1376-e1379

10.1093/cid/ciab361 Get It

Abstract In a large cohort of United States healthcare personnel without prior coronavirus disease 2019 (COVID-19) infection, 94 382 doses of messenger RNA (mRNA) COVID-19 vaccine were administered to 49 220 individuals. The adjusted vaccine effectiveness following 2 doses of each of the 2 available brands of mRNA vaccine exceeded 96%.